DEF: Alphatec Holdings Seeks Stockholder Approval for Key Proposals at 2025 Annual Meeting

Alphatec Holdings is asking stockholders to vote on the election of directors, ratification of the accounting firm, amendments to the equity incentive plan and certificate of incorporation, and executive compensation at the upcoming annual meeting.

Summary

• Alphatec Holdings, Inc. is holding its 2025 Annual Meeting of Stockholders on June 11, 2025, at its corporate headquarters in Carlsbad, CA.
• Stockholders are being asked to elect nine directors, ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm, approve an amendment to the 2016 Equity Incentive Plan to increase the number of shares authorized for issuance, and approve an amendment to the Certificate of Incorporation to increase the number of authorized shares of stock from 220,000,000 to 420,000,000.
• Additionally, stockholders will vote on an advisory basis to approve the compensation of the named executive officers.
• The Board of Directors recommends approval of each of the proposals.
• As of April 16, 2025, there were 146,118,365 shares of common stock outstanding and entitled to vote.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting routine proposals for stockholder vote. The tone is neutral and professional, with a clear recommendation from the board. The positive sentiment reflects the company's efforts to engage with stockholders and maintain corporate governance standards.

Positives

• The Board of Directors is actively seeking stockholder input on key governance and compensation matters.
• The company is providing multiple methods for stockholders to vote, including internet, telephone, and mail.
• The company is taking steps to conserve natural resources and lower delivery costs by providing proxy materials online.

Risks

• If the proposed amendments to the Equity Incentive Plan and Certificate of Incorporation are not approved, the company's ability to attract and retain talent and raise capital may be limited.
• The availability of additional shares of common stock for issuance could, under certain circumstances, discourage or make more difficult efforts to effect a change in control of the company or remove current management, which our stockholders might otherwise deem favorable.

Future Outlook

The company seeks to maintain flexibility in its equity compensation and capital structure to support future growth and strategic initiatives.

Management Comments

• Patrick S. Miles, President, Chief Executive Officer and Chairman of the Board, encourages stockholders to vote by proxy so that their shares will be represented and voted at the meeting.

Industry Context

The company operates in the medical technology sector, where attracting and retaining qualified personnel is highly competitive, making equity compensation plans a crucial tool.

Comparison to Industry Standards

• The compensation peer group for 2024 consisted of publicly traded healthcare companies against which Alphatec competes for executive talent.
• The peer group includes companies such as 10x Genomics, Inspire Medical Systems, Paragon 28, Artivion, iRhythm Technologies, Tandem Diabetes Care, AtriCure, Maravai LifeSciences Holdings, TransMedics Group, Axonics, Mesa Laboratories, Treace Medical Concepts, Doximity, Nevro, Glaukos, OraSure Technologies, Inari Medical, and Orthofix Medical.
• The company's revenue growth and TSR were compared to the 75th, 50th, and 25th percentiles of the peer group.

Related Party Transactions

• In December 2024, the Company's subsidiary, Alphatec Spine, Inc., entered into a four-year Master Consulting Services Agreement with David Demski, pursuant to which Mr. Demski agreed to provide, among other things, strategic advice and strategy with respect to areas of finance, accounting, sales operations, competitive recruitment and employee retention and marketing.
• Pursuant to the agreement, Mr. Demski received 126,051 RSUs.

Stakeholder Impact

• Approval of the proposals could impact shareholders through potential dilution and changes in control.
• Employees may be affected by changes to the equity incentive plan.
• The company's ability to attract and retain talent and raise capital could be affected by the outcome of the votes.

Next Steps

• Stockholders are urged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on June 11, 2025.
• The Board of Directors and Compensation Committee will review the voting results and consider them in future decisions regarding executive compensation.

Key Dates

Keywords

proxy statement, annual meeting, stockholders, directors, Deloitte & Touche, equity incentive plan, certificate of incorporation, executive compensation, Alphatec Holdings